{
    "Trade/Device Name(s)": [
        "One Step HCG Urine/Serum Test",
        "Wondfo One Step HCG Urine/Serum Test",
        "HCG Urine/Serum Test"
    ],
    "Submitter Information": "Guangzhou Wondfo Biotech Co., Ltd.",
    "510(k) Number": "K072500",
    "Predicate Device Reference 510(k) Number(s)": [
        "K980736"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DHA"
    ],
    "Summary Letter Date": "January 15, 2009",
    "Summary Letter Received Date": "January 21, 2009",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1155"
    ],
    "Regulation Name(s)": [
        "Human Chorionic Gonadotropin (HCG) Test System"
    ],
    "Analyte Class(es)": [
        "endocrine"
    ],
    "Analyte(s)": [
        "Human Chorionic Gonadotropin (HCG)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic assay",
        "Lateral flow",
        "Monoclonal antibody detection"
    ],
    "Methodologies": [
        "Qualitative detection"
    ],
    "Submission Type(s)": [
        "Test"
    ],
    "Document Summary": "FDA 510(k) summary for Wondfo One Step HCG Urine/Serum Test for qualitative detection of human chorionic gonadotropin in serum or urine.",
    "Indications for Use Summary": "Qualitative in vitro determination of human chorionic gonadotropin (HCG) in human serum or urine to aid in early detection of pregnancy; intended for professional (clinical laboratory) use only.",
    "fda_folder": "Clinical Chemistry"
}